article thumbnail

Pharmaceutical Patents: A Challenge for Malaysia

Contrarian Sales Techniques

It is noteworthy that Malaysia has a pharmaceutical manufacturing sector that almost exclusively produces generic drugs, with sales revenues amounting to only 1.5% of gross domestic product (GDP). I also note that the five largest companies typically sell originator drugs and account for 47 percent of total drug imports.